Skip to main content
. 2014 Feb 5;99(3):599–608. doi: 10.3945/ajcn.113.070524

TABLE 3.

Association between fish consumption and endometrial cancer risk in the VITamins And Lifestyle cohort

Categories of serving size–adjusted servings/wk P-trend1
Total fish (servings/wk) 0 0.01–1.00 1.01–2.10 2.11–3.08 ≥3.09
 No. of cases 11 68 74 37 54
 HR (95% CI)2 1.00 (reference) 1.46 (0.70, 3.06) 1.36 (0.65, 2.83) 1.54 (0.70, 3.37) 2.28 (1.07, 4.87) 0.010
Baked or broiled fish (servings/wk) 0 0.01–0.70 0.71–1.48 1.49–2.24 ≥2.25
 No. of cases 20 72 64 28 60
 HR (95% CI)2 1.00 (reference) 0.99 (0.57, 1.72) 0.91 (0.52, 1.59) 0.86 (0.46, 1.62) 1.72 (0.97, 3.04) 0.015
Canned tuna/tuna casserole (servings/wk) 0 0.01–0.21 0.22–0.35 0.36–0.56 ≥0.57
 No. of cases 48 57 18 61 60
 HR (95% CI)2 1.00 (reference) 1.07 (0.71, 1.63) 1.11 (0.63, 1.95) 1.24 (0.83, 1.86) 1.26 (0.83, 1.91) 0.195
White fish (servings/wk) 0 0.01–0.21 0.22–0.35 0.36–0.56 ≥0.57
 No. of cases 80 57 13 46 48
 HR (95% CI)2 1.00 (reference) 0.91 (0.63, 1.32) 0.84 (0.45, 1.60) 1.13 (0.77, 1.67) 1.33 (0.91, 1.95) 0.109
Dark or oily fish (servings/wk) 0 0.01–0.21 0.22–0.56 0.57–0.77 ≥0.78
 No. of cases 84 60 52 7 41
 HR (95% CI)2 1.00 (reference) 1.19 (0.83, 1.71) 1.12 (0.77, 1.63) 1.36 (0.62, 3.00) 1.44 (0.96, 2.17) 0.093
Shellfish, not fried (servings/wk) 0 0.01–0.21 0.22–0.35 0.36–0.56 ≥0.57
 No. of cases 118 50 13 35 28
 HR (95% CI)2 1.00 (reference) 1.00 (0.70, 1.42) 1.14 (0.62, 2.08) 1.36 (0.91, 2.03) 1.36 (0.86, 2.15) 0.069
Fried fish or shellfish (servings/wk) 0 0.01–0.21 0.22–0.35 0.36–0.56 ≥0.57
 No. of cases 134 56 7 29 18
 HR (95% CI)2 1.00 (reference) 1.30 (0.94, 1.81) 0.86 (0.40, 1.85) 1.22 (0.80, 1.87) 0.89 (0.53, 1.51) 0.890
1

Calculated by treating ordinal exposure variables as continuous in regression models.

2

Derived from Cox proportional hazards regression models. Adjusted for age (time variable), race, education, BMI, pack-years of smoking, physical activity, alcohol consumption, age at menarche, age at first birth, age at menopause, parity, years of combined hormone therapy, years of estrogen-only therapy, years of oral contraceptive use, oophoerectomy, family history of uterine cancer, family history of ovarian cancer, history of diabetes, and total energy.